(19)

(11)

EP 4 770 583 A1

(12)

(43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24772175.6 (22) Date of filing: 28.08.2024

(51) International Patent Classification (IPC):  A61F 2/40(2006.01) A61B 17/58(2006.01) A61F 2/30(2006.01) (52) Cooperative Patent Classification (CPC): A61F 2002/305; A61F 2/4059; A61F 2/4014; A61F 2002/4022; A61F 2002/4037; A61F 2002/4085; A61F 2002/30827; A61F 2002/3093; A61F 2002/30332; A61F 2002/30604; A61F 2002/30607; A61F 2002/30688; A61F 2002/30884; A61F 2002/3082; A61F 2002/30878; A61F 2002/30576; A61F 2002/30578; A61B 17/8061; A61B 17/8052 (86) International application number: PCT/US2024/044296 (87) International publication number: WO 2025/049652 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 29.08.2023 US 202363579354 P 21.02.2024 US 202463556023 P (71) Applicant: Encore Medical, L.P. Austin, Texas 78758 (US)	(72) Inventors: FRANKLE, Mark Alan Austin, Texas 78758 (US) GUTIERREZ, Sergio Austin, Texas 78758 (US) DIAZ, Miguel Alejandro Austin, Texas 78758 (US) (74) Representative: Botti & Ferrari S.p.A.  Via Cappellini, 11 20124 Milano 20124 Milano (IT)